Nascent Biotech Regains Worldwide Rights for Pritumumab
NORTH PALM BEACH, FL / ACCESSWIRE / May 26, 2023 / Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”, or the “Company”), a clinical-stage [...]
NBIO Link Report for May 10, 2023
Wall Street PR Apple News StreetInsider.com QuoteMedia WallStreetPR Facebook LinkedIn
Nascent Biotech to Present Phase I Clinical Data at American Society of Clinical Oncology Annual Meeting
NORTH PALM BEACH, FL / ACCESSWIRE / May 9, 2023 / Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”, or the “Company”), a clinical-stage [...]
A Letter to Nascent Biotech Shareholders, May 1, 2023
Dear Shareholder, Your continued support of Nascent Biotech is very much appreciated by the Company’s management. Without it, we could not have achieved the completion of our Phase I Clinical [...]